Dec 16, 2024
Galimedix Therapeutics initiates phase 1 trial of oral GAL-101
Author(s): David Hutton Key Takeaways GAL-101 targets misfolded amyloid beta monomers, preventing toxic oligomer and protofibril formation, with potential applications …
Resources
Dec 12, 2024
Exclusive 20% Off on Your Eye Care Essentials!
As part of our ongoing commitment to your eye health, we wanted to alert you about our partnership with …
Dec 10, 2024
‘Not all chocolate is created equal’: New data imply the dark variety lowers diabetes risk
By: Andrew (Drew) Rhoades Fact checked by: Gina Brockenbrough, MA Key takeaways: Eating 5 ounces or more of chocolate a …
Dec 10, 2024
ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy
By: Michela Cimberle Fact checked by Christine Klimanskis, ELS BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q …
Dec 9, 2024
Is Nutrition The Culprit? With Dr. Poteet
A new video discusses nutrition and its affects on our bodies and our eyes. Did you know your nutrition can …
Dec 3, 2024
Sun Pharma announces positive Phase 4 data results in dry eye disease
Author(s): David Hutton Key Takeaways Cyclosporine ophthalmic solution 0.09% significantly improves dry eye disease symptoms in patients inadequately controlled on …
Nov 27, 2024
Happy Thanksgiving
Happy Thanksgiving from our families to yours. We are grateful for your support and friendship. We will be closed on …
Nov 22, 2024
Adverum reports positive 52-week, 4-year data for wet AMD gene therapy
by: Alex Young & Anthony DeFino Adverum Biotechnologies reported positive 52-week data from the phase 2 LUNA trial as well …
Nov 22, 2024
Early positive data reported for geographic atrophy modifier gene therapy
Key takeaways: Low-dose OCU410 slowed lesion growth, preserved retinal tissue, and stabilized visual function in three patients. No drug-related serious …
Nov 18, 2024
Understanding blue light: Making sense of the spectrum
By Thomas A. Wong, OD, FAAO, FNAP & Karl Citek, OD, PhD, FAAO A new classification system helps patients reach informed …
Nov 18, 2024
4 favorite foods with the most toxic plasticizers
By Anastasia Climan, RDN, CD-N | Fact-checked by Barbara Bekiesz | Published November 15, 2024 Key Takeaways The use of phthalates in food processing and packaging has led …
Nov 12, 2024
Pistachios take over carrots as ultimate weapon for better, sharper vision?
Scientists have found nutty substitute for people seeking to improve eye health but dislike carrot by: Web Desk November 11, …
Nov 8, 2024
FDA grants de novo authorization to photobiomodulation device for dry AMD
Key takeaways: The light delivery system maintained vision in a trial among patients with dry age-related macular degeneration. It is …
Nov 7, 2024
Dropless cataract surgery: Shifting paradigm in postoperative care
Author(s): Monique M. Barbour, MD, Bria George, PharmD Key Takeaways Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence …
Nov 7, 2024
FDA clears investigational new drug application for wet AMD gene therapy
The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age-related macular degeneration, according to a press …
Nov 6, 2024
Intense pulsed light for treatment of dry eye disease
Author(s): David Hutton Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic’s campus in Phoenix, Arizona, …
Nov 4, 2024
UV protection for the eyes: What patients need to know
October 29, 2024, By Cristina M. Schnider, OD, MSc, MBA, FAAO Many people know that invisible UV light can cause a …
Oct 29, 2024
Daily consumption of pistachios boosts macular pigment optical density in healthy adults
October 28, 2024 Key takeaways: Eating 2 oz. of pistachios daily for 12 weeks significantly increased macular pigment optical density. …
Oct 28, 2024
Genetic Links Explored: How inherited retinal dystrophies affect refractive errors in patients
Specific genes associated with inherited retinal dystrophies (IRDs) also influence refractive errors (RE), such as myopia and hyperopia, according to …
Oct 28, 2024
Alkeus Pharmaceuticals announces topline results from SAGA trial on GA treatment
October 25, 2024 ew study about Geographic Atrophy By Jordana Joy, Associate Editor The data showed a 15.3% reduction in the …
Oct 23, 2024
#GIVING TUESDAY 2024
SAVE THE DATE: Tuesday December 3rd, 2024 #GivingTuesday—a movement to create a global day of giving Today. We need your …
Oct 22, 2024
Light therapy: Potential treatment for dry AMD
by: Lynda Charters Listen Key Takeaways Photobiomodulation may reduce visual loss and disease progression in dry AMD, offering a new …
Oct 7, 2024
Metformin Shows Promise for Treating Macular Degeneration in Mice
A new study shows metformin may help prevent vision loss associated with age-related macular degeneration. News Published: October 7, 2024 …
Sep 23, 2024
Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA
September 19, 2024 By David Hutton Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy lesion growth rate at …
Sep 19, 2024
Eye Drop Company in FDA’s Sights Once Again
The agency sounds alarm that products still may contain amniotic fluid by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today September …
Sep 16, 2024
These foods sabotage sleep
By Julia Ries | Fact-checked by Davi Sherman | Published September 13, 2024 Key Takeaways Certain foods like chocolate, greasy snacks, and spicy dishes can disrupt …
Sep 12, 2024
The Changing Landscape of Nutrition in Medicine
A look at developments that have propelled us forward and those still to come for eye care. by: Julie Poteet, …
Sep 11, 2024
Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment
Contrast sensitivity impairment showed the strongest relationship by Judy George, Deputy Managing Editor, MedPage TodaySeptember 5, 2024 Last Updated September 6, 2024 Key …
Sep 9, 2024
AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME
By David Hutton The Phase 1 trial is a multicenter, open-label, dose-escalation safety clinical trial, with 18 subjects, who each have …
Aug 21, 2024
AOA urges eye care provider consultation before use, purchase of MSM eye drops
August 20, 2024, By Jordana Joy, Associate Editor The alert follows a warning letter issued by the US FDA to a …